Yes, sequential use is reasonable and commonly done in clinical practice
GLP-1 weight loss uses medications that act on glucagon-like peptide-1 pathways, which are involved in appetite, fullness, digestion, and blood sugar regulation
Peptide Therapy Advanced peptide options designed to support recovery, longevity, and overall health with provider oversight
Medical weight loss treatments can have a profound impact on your body, extending beyond just reducing pounds on the scale
This research could also aid in creating new generations of obesity treatments by deepening our knowledge of the molecular aspects of weight control
Several hold FDA approval for specific indications